Table 1 Clinical outcome assessment (COA) types and definitions
From: Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review
Clinical Outcome Assessment Type | Abbreviation | Definition1 | N (%)3 |
|---|---|---|---|
Clinical assessment of treatment outcomes | - | Any clinical assessment of treatment benefit. This categorization included formal and informal evaluations by clinicians that did not explicitly utilize a COA, as well as those that utilized named ClinRO measures. | 99 (58.9) |
Clinician-reported outcome measures2 | ClinRO | A standardized measurement based on a report that comes from a trained health-care professional after observation of a patient’s health condition. | 31 (18.5) |
Patient-reported / Observer-reported outcome measures | PRO /ObsRO | Any measurement of health taken directly from the patient or an observer (defined here as a parent or caregiver, not a clinician). | 43 (25.6) |
Performance-based outcome measures | PerfO | A measurement based on standardized task(s) actively undertaken by a patient according to a set of instructions. | 9 (5.4) |
Other measures of health | - | Any measurement of health status that utilized external equipment such as thermography, ultrasound, MRI, photographs, and laboratory tests. | 67 (39.9) |